Introducing Invu by NuvoTM

Invu by Nuvo™ is an investigational, medical grade device designed for remote pregnancy monitoring. The patented technology is designed to detect signals including fetal heart rate, maternal heart rate, and uterine activity creating a comprehensive digital dashboard. The platform is designed for in-clinic and at home use.

Wearable Technology

The Invu Sensor Band™ is lightweight and easy to use. It is designed for accuracy, reliability and uses passive technology for safety.

Dynamic Cloud Computing Environment

Invu by Nuvo™ is enabled by cloud-based data capture and management. Digital signal processing and proprietary algorithms analyze data, allowing you to observe changes and evaluate trends that inform decisions about each pregnancy.

Unique Data Access and Visualization for Clinician and Mom

  • Clinician dashboard enables health care professionals to access patient vitals for timely decision-making.
  • Parent-facing app serves as a digital bridge to doctors, empowering parents with insights into the development of their unborn child.

Potential Benefits

  • Lower costs
  • Maximized resources
  • Higher patient satisfaction
  • Enables physicians to deliver leading edge care

Based on results from a meta-analysis

The platform

NuvoTM is pioneering a new remote monitoring platform. The future of pregnancy care combines our patented wearable device, dynamic cloud-based data capture, and knowledge-sharing across multiple access points.

Clinical dashboard

  • Clinical dashboard shares patient vitals with health care professionals and can be integrated with existing EHR systems

Data access on parent app

  • Patient app encourages engagement and empowerment
  • Enables communication between patient and doctor with existing EHR systems

Daily use of discrete wearable at home

  • Powered by state-of-the-art ECG and digital acoustic sensors
  • Designed for accuracy, reliability, and safety*
  • Additional devices for robust data capture

*FDA pre-market submission pending. Not yet available for sale in the U.S.

Clinical evidence

We are conducting a multisite pivotal trial with approximately 200 subjects, capturing cardiotocography (CTG) for both maternal and fetal heart rates. All data were captured with passive technology.

Learn more here

See our Poster from the 2019 Society for Reproductive Investigation (SRI) Meeting



core U.S. patents


granted patents worldwide


additional patents are pending


MEDICA® World Forum for Medicine
Top Innovative Company

Top 5 Wearable Health Problem Solver 2015

ImPACT Pediatric
Finalist in ImPACT Pediatric Health Pitch Competition
Finalist in Ernst & Young Digital Health Conference

Sign up for product updates, investment opportunities, or partnership opportunities.